Art industry looks tricky to navigate, with many sales private and some high risk, and scams not uncommon. So what are the wealthy buying these days, how safe are these investments, and what should they expect in terms of return? Betsy Bickar, senior vice president at...
This episode of the Market Dialogues focuses on airlines’ search for credible carbon offsets and low-carbon fuels, industry strategies to address these challenges, and implications for air travel demand and fare structures.
The Bloomberg Commodity Total Return Index had its best quarterly return in three years and the individual sectors all contributed positively except for grains which fell by 1%.
AWS’ Head of Climate Tech Business Development, Startups and Venture Capital Lisbeth Kaufman joins BI director of ESG research Eric Kane to discuss how she drew inspiration from The Toxic Avenger, and highlights real-world applications of computing and AI in fusion...
In this episode of FX Moment, BI’s Chief G10 FX Strategist Audrey Childe-Freeman talks to Bloomberg Economics Chief Trade and Climate Economist, Maeva Cousin, about what tariffs are already in place, what may follow, along with the likely implications on growth and...
“The most effective therapies for solid tumors are also the most toxic — and we need to fix that,” says Dr. John Connolly, chief scientific officer of the Parker Institute for Cancer Immunotherapy.
